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7%). Most of them (84%) also had associated infections
r diagnoses: pancytopenia (46%), Pneumocystis jirovecii
neumonia (38%) and candidiasis (30%); Kaposi sarcoma, dia-
etes, pulmonary tuberculosis and chronic diarrhea were
lso presented. CD4 count mean was 120 cells/mm3, CD8
ount mean was 571 cells/mm3, and viral load was 12,120
opies/mm3 log 3.22. CFR was 15%.
Conclusion: In this study neuroinfection was the ﬁrst
ause of hospitalization in HIV infected patients with
eurologic symptoms. Toxoplasmosis was the most com-
on opportunistic parenchymal brain lesion. The majority
f patients had associated other opportunistic diagnosis.
roper studies to determinate the real country prevalence
nd characteristics of these neuropathologies are necessary.
arly diagnosis is important in order to prevent potential
omplications and sequels. Even more, clinical follow-up
tudies of these infected patients are also needed in order
o evaluate the evolution of disease and development of
ssociated conditions.
oi:10.1016/j.ijid.2010.02.513
8.008
IV and opportunistic infections in a western hospital of
enezuela, 2007-2009
. Herrera-Martínez1,∗, Y. Herrera1, A.M. Pineda2
Hospital Central Antonio María Pineda, Barquisimeto,
ara, Venezuela
Hospital Central Antonio María Pineda, Barquisimeto,
enezuela
Background: Numerous opportunistic infections occur in
IV infected patients, particularly in those without access
o antiretroviral therapy. In Venezuela it is known a high
elationship between TB, PJP and candidiasis in HIV infected
atients.
Methods: We describe epidemiology, diagnosis and clini-
al features in HIV infected patients admitted to the Central
ospital of Barquisimeto, Western Venezuela, from January
007 to September 2009. Monthly records of conﬁrmed HIV
ases from the epidemiological archives were collected.
nly patients with opportunistic infections were selected.
ll the clinical relevant variables were considered in this
nalysis.
Results: A total of 228 patients with HIV infection were
reated in this medical center during the study period; Forty
hree (84%) were male; mean age was 36 years 51 (22%)
ad associated opportunistic infections.; Most cases due
o sexual transmission (96%), 56% were heterosexual, 75%
romiscuous, with a mean of four couples, beginning sex-
al relations at 17 years old. Fourteen (27%) patients had
revious HIV diagnosis, with a mean of 25 months, just 8
15%) were receiving treatment; 2/51 (4%) also had other
exual transmission diseases. Most common presented symp-
oms were fever 21/51 (41%), cough 19/51 (37%), weight
oss, vomits and dyspnea had also an important incidence
mong others. Half patients had anemia. Pneumonia was
he most common diagnosis 23/51 (45%), 65% caused by
neumocystis jirovecii; followed by wasting syndrome 18/51
35%), candidiasis (mucocutaneous, tracheal, esophagic),
ancytopenia 14/51 (27%), and chronic diarrhea 11/51 (21%)ternational Congress on Infectious Diseases (ICID) Abstracts
mong other diagnosis. TB had a low incidence during the
tudy period (11%). Patients, in which lymphocytic count
as available, had a CD4 count mean of 168 cells/mm3
nd CD8 count of 813 cells/mm3 and a viral load of 62,913
opies/mm3 log 3.06. CFR was 15%.
Conclusion: A signiﬁcant incidence of pneumonia due to
neumocystis jirovecii was observed. Since the introduc-
ion of HAART in Venezuela, a considerable reduction of
pportunistic infections was observed but HIV diagnosis usu-
lly occurs after opportunistic infections presentation, then,
roper diagnosis and prevention campaigns are for outmost
mportant not only in Venezuela, also in other developing
ountries in order to reduce the incidence of complications
nd to increase the quality of life of HIV infected patients.
oi:10.1016/j.ijid.2010.02.514
8.009
revalence of occult hepatitis B infection among HIV
nfected patients at an inner city clinic
. Nog ∗, K. Singaravelu, A. Haider, V. Sivapalan, S.
annheimer
Columbia University College Of Physicians and Surgeons
fﬁliation at Harlem Hospital Center, New York, NY, USA
Background: Morbidity and mortality is higher in HIV/HBV
oinfected than HIV monoinfected patients. Occult HBV
nfection i.e. isolated positive Hepatitis B core antibody
anti HBc) but Hepatitis B surface antigen (HBs Ag) and sur-
ace antibody (HBsAb) negative with HBV DNA is a form
f chronic HBV infection that impacts HIV management.
bjective: To determine the prevalence and patient char-
cteristics of occult hepatitis B infection in HIV infected
atients attending an outpatient HIV clinic in New York.
Methods: An electronic database of 630 HIV positive
atients at NYC Harlem Hospital Center’s Infectious Diseases
linic between June 2007 and January 2009 was reviewed.
otal of 82 patients with HBV serology showing HBsAg-,
BsAb -, anti HBc+ were identiﬁed. Of these 57 (69.5%) had
BV DNA testing information. Information on Demographic
ariables, Hepatitis C antibody (HCV Ab), antiretroviral ther-
py (ARV), CD4 and HIV viral load were collected.
Results: Among the ﬁnal study population, majority were
ales (n=36, 63.2%), African American (n=34, 59.6%), mean
ge of 48.7 ± 6.2yrs, on ARV (n=39, 70.2%), had CD4 > 200
n=44, 77.2%), VL < 50 (n=30, 52.6%) and 47.4% (n=27) tested
ositive for HCV. Approximately 7% (n=4) of study popu-
ation met the deﬁnition of occult HBV infection. 22% of
atients not on ARV (n=18) had positive HBV DNA, whereas
one of patients on ARV (0%, n=39) had detectable HBV DNA
p=0.007). All patients on ARV (n=39) were on a regimen
ith anti HBV activity. Of those with occult HBV infection,
0% (n=2) were males, 100% (n=4) were African American,
ean CD4 count was 408± 280, 75% (n=3) had HIV viral load
50, 100% were not on ARV and 75% tested positive for HCV.
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Prevalence of HCV by Occult HBV status
Conclusion: Though the overall prevalence of occult HBV
(7%) in our community clinic is lower than historical preva-
lence of 11%, among those not on ARV the prevelance was
much higher (22%). Further, high proportion of patients with
isolated anti HBc also tested positive for HCV ab (47.4%).
Therefore clinicians should have a high index of suspicion
for occult HBV among HIV infected patients whose hepati-
tis panel is positive only for core antibody.Clinicians should
have a high index of suspicion for occult HBV among HIV
infected patients whose hepatitis panel is positive only for
core antibody particularly those not on ARV and with HCV
coinfection.
doi:10.1016/j.ijid.2010.02.515
78.010
Predictors for hepatic carcinoma surveillance screening
in a cohort of hepatitis B and HIV coinfected patients in a
large urban HIV clinic
A. Adejumo1,∗, Z. Oshikanlu2, V. Sivapalan1
1 Columbia University College Of Physicians and Surgeons
afﬁliation at Harlem Hospital Center, New York, NY, USA
2 Columbia University College of Physicians and Surgeons
afﬁliation at Harlem Hospital, New York, NY, USA
Background: Co-infection with hepatitis B virus (HBV) and
HIV is common. Approximately 70-90% of HIV-infected indi-
viduals have evidence of past or active infection with HBV.
It is unclear what predicts the likelihood that patient with
active HBV/HIV infection will receive appropriate surveil-
lance screening for hepatic carcinoma. We hypothesized
that patients who have successful HIV treatment are likely to
have successful hepatic carcinoma surveillance screening.
Methods: To evaluate predictors for surveillance screen-
ing of hepatic carcinoma within the period of July 2008
to June 2009. A retrospective review of medical records
of patients with active HBV and HIV co-infection for hep-
atic ultrasound, alpha fetoprotein (AFP), liver biopsy, HBV
viral load, HBV e Ag screenings and gastroenterologist (GI)
referral.
Results: Of 77 HIV infected patients whose charts were
randomly selected, 55.8% (n =43) obtained care during the
study period. The demographic was 58% male (n=25). 7 of 43
patients (n =16.3%) had active HBV infection. All 7 patients
were referred for hepatic ultrasound, only 43% (n =3) had
the procedure performed with 66% (n =2) abnormal. All 7
patients had AFP screening, hepatitis B DNA measurement,
hepatitis B e Ag screening and GI referral. 1of 7 patients had
an elevated AFP while all 7 had detectable HBV DNA and 43%
l
3
a
wts e403
n =3) had positive hepatitis B e antigen. 71% (n =5) had an
nitial GI evaluation while only 28% (n =2) had >1 GI follow
p. 28% (n =2) were no show. None of the 7 patients had liver
iopsy.
In patients who did not obtain an abdominal ultrasound or
ho did not follow up with GI or no show, there was no signif-
cant difference in the CD4 count range when compared to
hose who obtained ultrasound or follow with GI. 57% (n =4)
f patients had issues with adherence as documented in the
hart. All 4 patients did not obtain abdominal ultrasound, 3
id not follow up with GI and 1 was no show.
Conclusion: 16.3% of our cohort of HBV/HIV co-infected
atients had active HBV infection. Non-adherence to fol-
ow up plan is the reason in patients who did not obtain
bdominal ultrasound or GI evaluation. CD4 count did not
ppear to be a predictor of probability to obtain hepatic car-
inoma screening. Strategies that improve adherence will
ikely improve the success of hepatic carcinoma surveillance
creening.
oi:10.1016/j.ijid.2010.02.516
8.011
irological and biochemical evolution of HIV-HBV co-
nfected patients treated with tenofovir
. Vidiella1,∗, P. Rios2, C. Biscayart3, S. Castillo4, A.
otas4, M. Christin5, D. Stamboulian6, P. Rodriguez
antorno4, C. Vujacich7
FUNCEI., Buenos Aires, Argentina
Hospital B Houssay, Buenos Aires, Argentina
Centros Médicos Dr. Stamboulian, Buenos Aires, Argentina
FUNCEI, Bs. As., Argentina
Clinica Olivos, Bs. As., Argentina
FUNCEI; Clinical Director, Ciudad Autonoma de Buenos
ires, Argentina
FUNCEI, BS.AS., Argentina
Background: Tenofovir (TDF) is a nucleotide with dual
ctivity against HIV and hepatitis B (HBV) viruses. Thus, it
as become the antiviral of choice for HIV-HBV co-infected
atients when treatment for both viral infections is indi-
ated.
Methods: We reviewed 19 medical records of patients
ho received tenofovir as part of the antiviral treatment.
ive patients had previously received 3TC (lamivudine) as
art of HAART. Immunological parameters were recorded for
IV infection (CD4/mm3), AST, ALT and viral loads for HIV
nd HBV were followed over an average period of 27 months
range, 3-44m).
Results: All patients were male and the median age was
2 years (range, 29-65). Concomitant antiviral medications
ere 1 NRTI +1 NNRTI (3TC/FTC) in 13 patients, 1 ritonavir-
oosted PI + 1 NNRTI in 1 patient, 1 PI + 1 NRTI (3TC or
TC) in 4 patients and 1 IP ritonavir-boosted + 2NRTI (AZT +
TC) in 1 patient. The mean HBV DNA at baseline was: 6.53
og. Six patients presented at baseline with normal ALT and
3 a mean elevation of AST/ALT x 3,8/x 5. The results of
iver biopsy were available for 6 patients: 1 had cirrhosis,
mild chronic hepatitis (stage 1), 2 moderate chronic hep-
titis (stage 2). 17 patients were HBeAg positive, and two
ere HBeAg negative at baseline. Seven out of 17 patients
